First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing

BACKGROUND: The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. OBJECTIVE: To assess outcomes associated with excipient skin testing after a reported allergic reacti...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Allergy Clin Immunol Pract
Egile Nagusiak: Wolfson, Anna R., Robinson, Lacey B., Li, Lily, McMahon, Aubree E., Cogan, Amelia S., Fu, Xiaoqing, Wickner, Paige, Samarakoon, Upeka, Saff, Rebecca R., Blumenthal, Kimberly G., Banerji, Aleena
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Academy of Allergy, Asthma & Immunology 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8217699/
https://ncbi.nlm.nih.gov/pubmed/34166844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2021.06.010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak